We are live on ! Find out more
NM

Newtyn Management Portfolio holdings

AUM $801M
1-Year Est. Return 23.14%
This Fund
S&P 500
This Quarter Est. Return
+13.87%
1 Year Est. Return
+23.14%
3 Year Est. Return
+51.97%
5 Year Est. Return
+52.71%
10 Year Est. Return
+183.03%
AUM
$651M
AUM Growth
+$119M
Cap. Flow
+$50.5M
Cap. Flow %
7.76%
Top 10 Hldgs %
62.03%
Holding
44
New
4
Increased
9
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
HE icon
Hawaiian Electric Industries
HE
+$35.7M
2
EDR
Endeavor Group Holdings, Inc.
EDR
+$30.9M
3
TBPH icon
Theravance Biopharma
TBPH
+$20.6M
4
CNNE icon
Cannae Holdings
CNNE
+$15.5M
5
INDV icon
Indivior Pharmaceuticals
INDV
+$10.2M

Top Sells

Rank Stock Value
1
VTOL icon
Bristow Group
VTOL
+$18.7M
2
PAR icon
PAR Technology
PAR
+$14.3M
3
OFIX icon
Orthofix Medical
OFIX
+$13.7M
4
SOLV icon
Solventum
SOLV
+$11.9M
5
SHC icon
Sotera Health
SHC
+$11.3M

Sector Composition

Rank Sector Weight
1 Healthcare 29.84%
2 Communication Services 22.82%
3 Real Estate 11.67%
4 Technology 9.45%
5 Utilities 5.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCG icon
26
PG&E
PCG
$36.6B
$5.32M 0.82%
268,921
– –
GRAL
27
GRAIL Inc
GRAL
$3.57B
$5.08M 0.78%
369,097
+334,828
+977% +$5.08M
FBTC icon
28
Fidelity Wise Origin Bitcoin Fund
FBTC
$14.4B
$4.83M 0.74%
87,000
– –
WVE icon
29
Wave Life Sciences
WVE
$993M
$3.48M 0.53%
425,000
-50,000
-11% -$299K
ABEO icon
30
Abeona Therapeutics
ABEO
$339M
$2.4M 0.37%
380,000
– –
KOD icon
31
Kodiak Sciences
KOD
$2.37B
$1.93M 0.3%
740,505
-189,495
-20% -$504K
MURA
32
DELISTED
Mural Oncology
MURA
$1.78M 0.27%
570,000
– –
ETNB
33
DELISTED
89bio
ETNB
$1.78M 0.27%
240,000
– –
OLMA icon
34
Olema Pharmaceuticals
OLMA
$899M
$1.67M 0.26%
140,000
– –
MAGN
35
Magnera Corp
MAGN
$441M
$1.6M 0.25%
+68,443
New +$1.43M
AVIR icon
36
Atea Pharmaceuticals
AVIR
$430M
$1.27M 0.2%
380,000
– –
BDTX icon
37
Black Diamond Therapeutics
BDTX
$128M
$413K 0.06%
95,000
– –
BOLT icon
38
Bolt Biotherapeutics
BOLT
$7.34M
$304K 0.05%
23,446
-44,716
-66% -$616K
LFLYW
39
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$20.1K ﹤0.01%
634,640
– –
ALGS icon
40
Aligos Therapeutics
ALGS
$43.1M
– –
-28,771
Closed -$252K
FET icon
41
Forum Energy Technologies
FET
$907M
– –
-15,000
Closed -$253K
SHC icon
42
Sotera Health
SHC
$5.5B
– –
-950,000
Closed -$11.3M
EQC
43
DELISTED
Equity Commonwealth
EQC
– –
-163,913
Closed -$3.18M
1
2

Similar funds

LWM
Liberty Wealth Management Oakland, California $800M AUM 22.73% 1-Year Est. Return
CCM
Corsair Capital Management New York $800M AUM 94.38% 1-Year Est. Return
HW
HORAN Wealth Cincinnati, Ohio $800M AUM 23.65% 1-Year Est. Return
LOPW
Live Oak Private Wealth Wilmington, North Carolina $800M AUM 24.59% 1-Year Est. Return
BBPWM
Blue Bell Private Wealth Management Blue Bell, Pennsylvania $802M AUM 22.13% 1-Year Est. Return
WLIM
White Lighthouse Investment Management Bedford, Massachusetts $802M AUM 19.15% 1-Year Est. Return
KFAA
Klaas Financial Asset Advisors Loves Park, Illinois $803M AUM 13.2% 1-Year Est. Return
JJ
Johnson & Johnson New Brunswick, New Jersey $799M AUM 253.51% 1-Year Est. Return

Newtyn Management's Q3 2024 Portfolio in Review

As of Q3 2024, Newtyn Management held 44 positions worth $651M, up 22% from $533M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Newtyn Management deployed $50.5M of net new capital in Q3 2024, opening 4 new positions and adding to 9 existing holdings. Its largest new stake was Hawaiian Electric Industries: 2,882,512 shares worth $27.9M.

By sector, the portfolio is most concentrated in Healthcare at 30% of assets, down from 30% a quarter earlier, followed by Communication Services and Real Estate.

On the sell side, the largest reduction was Bristow Group, an estimated $18.7M trimmed.

  • Newtyn Management's largest Q3 2024 buy was Hawaiian Electric Industries: 2,882,512 shares worth $27.9M.
  • Newtyn Management added most to Theravance Biopharma in Q3 2024, an estimated $20.6M increase.
  • Newtyn Management's biggest Q3 2024 reduction was Bristow Group, cutting an estimated $18.7M.
  • Newtyn Management fully exited Sotera Health in Q3 2024, selling an estimated $11.3M.
  • Newtyn Management's ten largest holdings make up 62% of its $651M portfolio in Q3 2024.
  • Newtyn Management opened 4 new positions and closed 4 in Q3 2024.
  • Newtyn Management's portfolio value rose 22% quarter-over-quarter to $651M.

Based on Newtyn Management's 13F filing for Q3 2024, filed 14 Nov 2024.